SUMMARY. Photosensitization of the skin by demethylchlortetracycline and sulphanilamide has been demonstrated in mice. Demethylchlortetracycline has an action spectrum extending from 350 to 420 nm with a peak at 400 nm; it is most effective in mice when given by the intradermal route, less effective intraperitoneally and without action orally. Sulphanilamide has a photosensitizing action spectrum from 375 to 400 nm, i.e. mostly in the visible spectrum, with less certain activity at 280–300 and 550–600 nm; it is effective intradermally and inactive orally. The majority of the photosensitizing effects of sulphanilamide must be due either to the alteration of its constitution in the skin, or to a metabolic change in the skin itself since sulphanilamide does not absorb visible light. Possible mechanisms are discussed and a speculative hypothesis is proposed that a local disturbance of porphyrin metabolism may be implicated.
No takes yet. Share an insight, caveat, or question.
Stratigos et al. (1968) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: